Patents by Inventor Jonah Shacknai

Jonah Shacknai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170151149
    Abstract: There is provided a topical skin composition directed to one or more desired benefits. The composition includes one or more proteins selected based on the desired skin benefit to be derived by application of the topical skin composition. In one embodiment, each protein is from one donor group having two or more individuals. In another embodiment, the protein is from two or more donor group.
    Type: Application
    Filed: November 30, 2016
    Publication date: June 1, 2017
    Inventors: Jonah SHACKNAI, Mitchell S. WORTZMAN, David H. McDANIEL, Stephen NEWHART
  • Publication number: 20150132267
    Abstract: The present disclosure provides a non-autologous product that is a mixture of two or more cells or tissue cultures of fibroblast, or extracts from cultures, or media cultures, isolated from separate individuals, either homogeneous or heterogeneous. The cells or factors are blended together in a product that imparts desired characteristics to the skin of a recipient who is not a source of the mixture. The present disclosure also relates to methods of making and using and/or culturing the fibroblasts including to optimize the potency of the mixture to impart one or more the desired characteristics to the skin of a recipient.
    Type: Application
    Filed: November 14, 2014
    Publication date: May 14, 2015
    Inventors: Jonah SHACKNAI, Mitchell S. WORTZMAN, David H. McDANIEL
  • Patent number: 6955825
    Abstract: A composition and method for delivering sulfur to skin and absorbing irritants in the skin. A high sorption base is employed which comprises non-swelling clay, gum, swelling clay, silicon and combinations thereof. The absorption of the irritants does not hinder the delivery of the active ingredient to the skin.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: October 18, 2005
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Jonah Shacknai, Eugene H. Gans
  • Patent number: 6905675
    Abstract: A method for reducing the production of malodor in sulfur containing dermatological compositions by adjusting the pH of the composition to between about 6.5 to about 8.1. Also, sulfur containing dermatological compositions having a pH between about 6.5 and about 8.1.
    Type: Grant
    Filed: October 29, 2002
    Date of Patent: June 14, 2005
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Jonah Shacknai, Eugene H. Gans, Ray Figureoa
  • Patent number: 6855342
    Abstract: A composition and method for delivering sulfur to skin and absorbing irritants in the skin. A high sorption base is employed which comprises non-swelling clay, gum, swelling clay, silicon and combinations thereof. The absorption of the irritants does not hinder the delivery of the active ingredient to the skin.
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: February 15, 2005
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Jonah Shacknai, Eugene H. Gans
  • Publication number: 20040202729
    Abstract: A composition and method for delivering sulfur to skin and absorbing irritants in the skin. A high sorption base is employed which comprises non-swelling clay, gum, swelling clay, silicon and combinations thereof. The absorption of the irritants does not hinder the delivery of the active ingredient to the skin.
    Type: Application
    Filed: April 21, 2004
    Publication date: October 14, 2004
    Inventors: Jonah Shacknai, Eugene H. Gans
  • Patent number: 6787160
    Abstract: A composition and method for delivering sulfur to skin and absorbing irritants in the skin. A high sorption base is employed which comprises non-swelling clay, gum, swelling clay, silicon and combinations thereof. The absorption of the irritants does not hinder the delivery of the active ingredient to the skin.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: September 7, 2004
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Jonah Shacknai, Eugene H. Gans
  • Publication number: 20040057972
    Abstract: A method for reducing the production of malodor in sulfur containing dermatological compositions by adjusting the pH of the composition to between about 6.5 to about 8.1. Also, sulfur containing dermatological compositions having a pH between about 6.5 and about 8.1.
    Type: Application
    Filed: October 29, 2002
    Publication date: March 25, 2004
    Applicant: MEDICIS PHARMACEUTICAL CORPORATION
    Inventors: JONAH SHACKNAI, Eugene H. Gans, Ray Figureoa
  • Publication number: 20030161895
    Abstract: A composition and method for delivering sulfur to skin and absorbing irritants in the skin. A high sorption base is employed which comprises non-swelling clay, gum, swelling clay, silicon and combinations thereof. The absorption of the irritants does not hinder the delivery of the active ingredient to the skin.
    Type: Application
    Filed: December 20, 2002
    Publication date: August 28, 2003
    Inventors: Jonah Shacknai, Eugene H. Gans
  • Publication number: 20030133959
    Abstract: A method for reducing the production of malodor in sulfur containing dermatological compositions by adjusting the pH of the composition to between about 6.5 to about 8.1. Also, sulfur containing dermatological compositions having a pH between about 6.5 and about 8.1.
    Type: Application
    Filed: October 29, 2002
    Publication date: July 17, 2003
    Inventors: Jonah Shacknai, Eugene H. Gans, Ray Figureoa
  • Patent number: 6514489
    Abstract: A method for reducing the production of malodor in sulfur containing dermatological compositions by adjusting the pH of the composition to between about 6.5 to about 8.1. Also, sulfur containing dermatological compositions having a pH between about 6.5 and about 8.1.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: February 4, 2003
    Assignee: Medicis Pharmaceutical Corp.
    Inventors: Jonah Shacknai, Eugene H. Gans, Ray Figureoa
  • Publication number: 20020164381
    Abstract: Methods for the treatment and prevention of cutaneous mites and for the treatment and prevention of cutaneous inflammation of mammalian skin associated with cutaneous mite infestations utilizing compositions comprising sulfur, one or more sulfur derivative and a dermatologically acceptable carrier. The composition is preferably a cleanser.
    Type: Application
    Filed: December 18, 2001
    Publication date: November 7, 2002
    Applicant: Medicis Pharmaceutical Corporation
    Inventors: Jonah Shacknai, Eugene H. Gans
  • Publication number: 20020132015
    Abstract: A composition and method for delivering sulfur to skin and absorbing irritants in the skin. A high sorption base is employed which comprises non-swelling clay, gum, swelling clay, silicon and combinations thereof. The absorption of the irritants does not hinder the delivery of the active ingredient to the skin.
    Type: Application
    Filed: December 18, 2001
    Publication date: September 19, 2002
    Applicant: Medicis Pharmaceutical Corporation
    Inventors: Jonah Shacknai, Eugene H. Gans
  • Patent number: 5648389
    Abstract: The present invention provides compositions and methods for alleviation of both visible and non-visible, or pre-emergent, dermatological lesions associated with changes in normal keratinization, cutaneous infection, epidermal formation or pilosebaceous function, such as acne, psoriasis, seborrhea, ingrown hairs and pseudofolliculitis barbae, and hyperpigmented skin. The inventive compositions comprise a dermatologically absorbable topical antimicrobial, antibiotic, antibacterial or antifungal agent; a dermatologically absorbable alpha or beta hydroxy acid; and a dermatologically absorbable zinc compound in a suitable carrier.
    Type: Grant
    Filed: October 27, 1995
    Date of Patent: July 15, 1997
    Assignee: Medicis Pharmaceutical, Inc.
    Inventors: Eugene H. Gans, Jonah Shacknai
  • Patent number: 5114963
    Abstract: The present invention is a method for lowering serum levels of Lp(a), thereby reducing the risk of atherosclerotic disease. Specifically, the present invention comprises administering an effective amount of a N,S-diacyl-L-cysteine to a human or animal with elevated serum levels of Lp(a). The N,S-diacyl-L-cysteines comprise a compound selected from the group having the formula: ##STR1## wherein R is selected from the group consisting of hydrogen and an alkyl group containing 1 to 8 carbon atoms and R' is selected from the group consisting of acetyl, benzoly, thenoyl, 2-chromone-carbonyl and succinyl, and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: March 13, 1991
    Date of Patent: May 19, 1992
    Assignee: Medicis Corporation
    Inventors: John W. Holaday, Jonah Shacknai, Leonard L. Mazur